ETHANOL LEAF EXTRACT OF FICUS EXASPERATA ATTENUATES CHANGES IN ELECTROLYTES AND LIPID PROFILES IN A RAT MODEL OF OLANZAPINE-INDUCED OBESITY
Abstract
Obesity is a major public health concern characterized by excessive body fat, which increases the risk of numerous health conditions, including heart disease, diabetes, high blood pressure, and certain cancers. Addressing obesity is crucial for improving overall health and well-being. In this study, thirty female Wistar rats, weighing between 190 and 200 g, were utilized to investigate the effects of Ficus exasperata on olanzapine-induced obesity. After a two-week acclimatization period, obesity was induced in the designated group using olanzapine (4 mg/kg) via oral gavage for 28 days. The rats were then divided into five groups (n = 6): normal control, obese-untreated, non-obese treated with Ficus exasperata (100 mg/kg), obese treated with Ficus exasperata (100 mg/kg), and obese treated with orlistat (100 mg/kg). Treatments were administered orally for 28 days. At the end of the study, the animals were sacrificed, and blood samples were collected for serum analysis. The study demonstrated that Ficus exasperata significantly (P< 0.05) increases bicarbonate and potassium while reducing sodium and calcium (P< 0.05). Ficus exasperata significantly (P< 0.05) reduces HDL with a significant (P< 0.05) increase in TC, TG and LDL. These findings suggest that Ficus exasperata influences both electrolyte balance and lipid metabolism in obese animals.
References
Abotsi, W. M., Woode, E., Ainooson, G. K., Amo-Barimah, A. K., & Boakye-Gyasi, E. (2010). Antiarthritic and antioxidant effects of the leaf extract of Ficus exasperata P. Beauv. (Moraceae). Pharmacognosy Research, 2(2), 8997. https://doi.org/10.4103/0974-8490.62958
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Annett, S., Boison, D., Burns, K. E., Dessauer, C., Gertsch, J., Helsby, N. A., Izzo, A. A., Ostrom, R., Papapetropoulos, A., ... Wong, S. S. (2023). The concise guide to PHARMACOLOGY 2023/24: Enzymes. British Journal of Pharmacology, 180(S2). https://doi.org/10.1111/bph.16181
Alptekin, . M., akrolu, F. P., Reber, T., & Nemutlu, E. (2024). Inulin may prevent the high-fat diet induced-obesity via suppressing endocannabinoid system in the prefrontal cortex in Wistar rats. International Journal of Food Sciences and Nutrition, 75(8), 800811. https://doi.org/10.1080/09637486.2024.2408545
Awoyemi, T., Guzman, R. B., & Naveed, A. (2024). Olanzapineinduced cardiomyopathy: A mimicker of obesity cardiomyopathy? Clinical Cardiology, 47(5), e24278.
Balbo, M. S., Hallak, J. E. C., Nunes, E. A., Triffoni-Melo, T., Ferreira, S., Chaves, C., Duro, A. M. S., Ramos, A. P. P., Crippa, S., & Costa Queiroz, R. H. (2014). Olanzapine, weight change and metabolic effects: A naturalistic 12-month follow-up. Therapeutic Advances in Psychopharmacology, 4(1), 30. https://doi.org/10.1177/2045125313507738
Bingol, Z., Phtl, A., Cagatay, P., Okumus, G., & Kyan, E. (2015). Clinical predictors of obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea. Respiratory Care, 60(5), 666672. https://doi.org/10.4187/respcare.03733
Bruijn, N., Van Lohuizen, R., Boron, M., Fitzek, M., Gabriele, F., Giuliani, G., Melgarejo, L., ehulka, P., Sebastianelli, G., Triller, P., Vigneri, S., zcan, B., & Van Den Brink, A. M. (2024). Influence of metabolic state and body composition on the action of pharmacological treatment of migraine. The Journal of Headache and Pain, 25(1). https://doi.org/10.1186/s10194-024-01724-3
Chang, C., Goh, K. K., & Lu, L. (2021). Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World Journal of Psychiatry, 11(10), 696. https://doi.org/10.5498/wjp.v11.i10.696
Chen, C., Nakano, T., Hsu, W., Chu, C. Y., & Huang, T. (2022). Early lipid metabolic effects of the anti-psychotic drug olanzapine on weight gain and associated gene expression. Neuropsychiatric Disease and Treatment, 18, 645. https://doi.org/10.2147/NDT.S345046
Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177
Ellis, L. R., Zulfiqar, S., Holmes, M., Marshall, L., Dye, L., & Boesch, C. (2022). A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutrition Reviews, 80(6), 1723. https://doi.org/10.1093/nutrit/nuab104
Ellulu, M. S., Patimah, I., Khaza'ai, H., Rahmat, A., & Abed, Y. (2017). Obesity and inflammation: The linking mechanism and the complications. Archives of Medical Science, 13(4), 851863. https://doi.org/10.5114/aoms.2016.58928
George, T. T., Oyenihi, A. B., Oyenihi, O. R., & Obilana, A. O. (2023). Composition and health-promoting effects of fig (Ficus carica) extracts. In Fig (Ficus carica): Production, processing, and properties (pp. 561578). Springer. https://doi.org/10.1007/978-3-031-16493-4_25
Ghai, R., Chaudhary, S., Nagarajan, K., Goel, R., et al. (2023). An investigative study of medicinal herbs for anti-obesity potential. Oriental Journal of Chemistry, 39. https://doi.org/10.13005/ojc/390605
Hamm, L. L., Nakhoul, N., & Hering-Smith, K. S. (2015). Acid-base homeostasis. Clinical Journal of the American Society of Nephrology, 10(12), 22322242. https://doi.org/10.2215/CJN.07400715
Harahap, I. A., Landrier, J. F., & Suliburska, J. (2022). Interrelationship between Vitamin D and Calcium in obesity and its comorbid conditions. Nutrients, 14(15), 3187. https://doi.org/10.3390/nu14153187
Hasan, B., Nayfeh, T., Alzuabi, M., Wang, Z., Kuchkuntla, A. R., Prokop, L. J., Newman, C. B., Murad, M. H., & Rajjo, T. I. (2020). Weight loss and serum lipids in overweight and obese adults: A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 105(12), dgaa673. https://doi.org/10.1210/clinem/dgaa673
Hasnat, H., Alam, S., Shompa, S. A., et al. (2024). Phyto-pharmacological wonders of genus Ficus: Ethnopharmacological insights and phytochemical treasures from natural products. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102211
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2021). Recent molecular mechanisms and beneficial effects of phytochemicals and plant-based whole foods in reducing LDL-C and preventing cardiovascular disease. Antioxidants (Basel), 10(5), 784. https://doi.org/10.3390/antiox10050784
Kofie, W., Osman, H., & Bekoe, S. O. (2015). Phytochemical properties of extracts and isolated fractions of leaves and stem bark of Ficus exasperata. World Journal of Pharmacy and Pharmaceutical Sciences, 4.
Kolb, H., Kempf, K., & Rhling, M. (2021). Ketone bodies: From enemy to friend and guardian angel. BMC Medicine, 19, 313. https://doi.org/10.1186/s12916-021-02185-0
Kuhn, C., Mohebbi, N., & Ritter, A. (2024). Metabolic acidosis in chronic kidney disease: Mere consequence or also culprit? Pflgers Archiv - European Journal of Physiology, 476, 579592. https://doi.org/10.1007/s00424-024-02912-5
Laguado, S. A., & Saklad, S. R. (2022). Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review. Mental Health Clinician, 12(4), 254262. https://doi.org/10.9740/mhc.2022.08.254
Lian, J., Huang, F., Pai, N., & Deng, C. (2014). Preventing olanzapine-induced weight gain using betahistine: A study in a rat model with chronic olanzapine treatment. PLOS ONE, 9(8), e104160. https://doi.org/10.1371/journal.pone.0104160
Lingvay, I., Cohen, R. V., le Roux, C. W., & Sumithran, P. (2024). Obesity in adults. The Lancet, 404(10456), 972987.
Lund, B. C., & Perry, P. J. (2000). Olanzapine: An atypical antipsychotic for schizophrenia. Expert Opinion on Pharmacotherapy, 1(2), 305323. https://doi.org/10.1517/14656566.1.2.305
Mahboob, A., Samuel, S. M., Mohamed, A., Wani, M. Y., et al. (2023). Role of flavonoids in controlling obesity: Molecular targets and mechanisms. Frontiers in Nutrition, 10, 1177897. https://doi.org/10.3389/fnut.2023.1177897
Mathus-Vliegen, L., Toouli, J., Fried, M., Khan, A. G., Garisch, J., Hunt, R., Fedail, S., timac, D., Lemair, T., Krabshuis, J., Kaufmann, P., Roberts, E., & Riccardi, G. (2012). World Gastroenterology Organisation global guidelines on obesity. Journal of Clinical Gastroenterology, 46(7), 555561. https://doi.org/10.1097/mcg.0b013e318259bd04
Musabayane, C. T. (2012). The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovascular Journal of Africa, 23(8), 462468. https://doi.org/10.5830/CVJA-2012-025
Mutiso, S. K., Rono, D. K., & Bukachi, F. (2014). Relationship between anthropometric measures and early electrocardiographic changes in obese rats. BMC Research Notes, 7, 931. https://doi.org/10.1186/1756-0500-7-931
Nagami, G. T., & Kraut, J. A. (2024). The role of the endocrine system in the regulation of acidbase balance by the kidney and the progression of chronic kidney disease. International Journal of Molecular Sciences, 25(4), 2420. https://doi.org/10.3390/ijms25042420
Narasimhan, M., Bruce, T. O., & Masand, P. (2007). Review of olanzapine in the management of bipolar disorders. Neuropsychiatric Disease and Treatment, 3(5), 579. https://pmc.ncbi.nlm.nih.gov/articles/PMC2656294
Nawaz, H., Waheed, R., & Nawaz, M. (2020). Phytochemical composition, antioxidant potential, and medicinal significance of ficus. In IntechOpen eBooks. https://doi.org/10.5772/intechopen.86562
NCD Risk Factor Collaboration (NCD-RisC). (2024). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. The Lancet, 403(10431), 10271050.
Noce, A., Marrone, G., Jones, G. W., Lauro, M. D., Zaitseva, A. P., Ramadori, L., Celotto, R., Mitterhofer, A. P., & Daniele, N. D. (2021). Nutritional approaches for the management of metabolic acidosis in chronic kidney disease. Nutrients, 13(8), 2534. https://doi.org/10.3390/nu13082534
Novelli, E. L. B., Diniz, Y. S., Galhardi, C. M., Ebaid, G. M. X., Rodrigues, H. G., Mani, F., Fernandes, A. A. H., Cicogna, A. C., & Novelli Filho, J. L. V. B. (2007). Anthropometrical parameters and markers of obesity in rats. Laboratory Animals, 41(1), 111119. https://doi.org/10.1258/002367707779399518
Nworu, C. S., Nwuke, H. C., Akah, P. A., Okoye, F. B., & Esimone, C. O. (2013). Extracts of Ficus exasperata leaf inhibit topical and systemic inflammation in rodents and suppress LPS-induced expression of mediators of inflammation in macrophages. Journal of Immunotoxicology, 10(3), 302310. https://doi.org/10.3109/1547691X.2012.732121
Okunogbe, A., Nugent, R., Spencer, G., Powis, J., Ralston, J., & Wilding, J. (2022). Economic impacts of overweight and obesity: Current and future estimates for 161 countries. BMJ Global Health, 7(9), e009773. https://doi.org/10.1136/bmjgh-2022-009773
Park, K. (2023). The role of dietary phytochemicals: Evidence from epidemiological studies. Nutrients, 15(6), 1371. https://doi.org/10.3390/nu15061371
Ruban, A., Glaysher, M. A., Miras, A. D., Goldstone, A. P., Prechtl, C. G., Johnson, N., Li, J., Aldhwayan, M., Aldubaikhi, G., Glover, B., Lord, J., Onyimadu, O., Falaschetti, E., Klimowska-Nassar, N., Ashrafian, H., Byrne, J., & Teare, J. P. (2020). A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: A RCT. Efficacy and Mechanism Evaluation, 7(6), 1130. https://doi.org/10.3310/eme07060
Shapses, S. A., & Sukumar, D. (2012). Bone metabolism in obesity and weight loss. Annual Review of Nutrition, 32, 287309. https://doi.org/10.1146/annurev.nutr.012809.104655
Suburu, J., Gu, Z., Chen, H., Chen, W., Zhang, H., Chen, Y. Q. (2013). Fatty acid metabolism: Implications for diet, genetic variation, and disease. Food Bioscience, 4, 112. https://doi.org/10.1016/j.fbio.2013.07.003
Tobar Leito, S. A., Soares, D. D. S., Carvas Junior, N., Zimmer, R., Ludwig, N. F., & Andrades, M. (2021). Study of anesthetics for euthanasia in rats and mice: A systematic review and meta-analysis on the impact upon biological outcomes (SAFE-RM). Life Sciences, 284, 119916. https://doi.org/10.1016/j.lfs.2021.119916
Umaru, I. J., Samuel, O. S., Kerenhappuch, I. U., Yakub, O. E., et al. (2022). Hypertension and plant extract as a solution. Clinical Cardiovascular Research, 1(1). https://doi.org/10.58489/2836-5917/004
Wjcik, M., & Kozio-Kozakowska, A. (2021). Obesity, sodium homeostasis, and arterial hypertension in children and adolescents. Nutrients, 13(11), 4032. https://doi.org/10.3390/nu13114032
Xie, P., Shao, T., & Long, Y. (2024). Orlistat for the treatment of antipsychotic-induced weight gain: An eight-week multicenter, randomized, placebo-controlled, double-blind trial. Lipids in Health and Disease, 23(225). https://doi.org/10.1186/s12944-024-02214-w
Yang, Y., & Wu, R. (2025). Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain. European Archives of Psychiatry and Clinical Neuroscience, 275, 619627. https://doi.org/10.1007/s00406-025-01965-6
Yang, Y., Xie, P., & Long, Y. (2022). Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments. BMC Psychiatry, 22(210). https://doi.org/10.1186/s12888-022-03853-y
Copyright (c) 2025 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
